Kelyniam Global Inc
Kelyniam Global, Inc., a medical device manufacturing company, engages in the production of custom prosthetics cranial implants utilizing computer aided design, and computer aided manufacturing of advanced medical grade polymers in the United States. The company is also involved in the development, manufacture, and distribution of custom cranial implant for patients requiring the reconstruction o… Read more
Kelyniam Global Inc (KLYG) - Total Assets
Latest total assets as of March 2025: $1.73 Million USD
Based on the latest financial reports, Kelyniam Global Inc (KLYG) holds total assets worth $1.73 Million USD as of March 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Kelyniam Global Inc - Total Assets Trend (2006–2024)
This chart illustrates how Kelyniam Global Inc’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Kelyniam Global Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
Kelyniam Global Inc's total assets of $1.73 Million consist of 32.5% current assets and 67.5% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 8.7% |
| Accounts Receivable | $385.57K | 21.8% |
| Inventory | $34.79K | 2.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $23.30K | 1.3% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2006–2024)
This chart illustrates how Kelyniam Global Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Kelyniam Global Inc's current assets represent 32.5% of total assets in 2024, an increase from 12.6% in 2006.
- Cash Position: Cash and equivalents constituted 8.7% of total assets in 2024, up from 2.4% in 2006.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 1.0% of total assets, an increase from 0.0% in 2006.
- Asset Diversification: The largest asset category is accounts receivable at 21.8% of total assets.
Kelyniam Global Inc Competitors by Total Assets
Key competitors of Kelyniam Global Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
Kelyniam Global Inc - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Strong asset utilization - Kelyniam Global Inc generates 1.88x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Kelyniam Global Inc is currently not profitable relative to its asset base.
Kelyniam Global Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.76 | 0.86 | 0.79 |
| Quick Ratio | 0.70 | 0.77 | 0.70 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-177.39K | $ -73.24K | $ -126.29K |
Kelyniam Global Inc - Advanced Valuation Insights
This section examines the relationship between Kelyniam Global Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | - |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 8.3% |
| Total Assets | $1.77 Million |
| Market Capitalization | $1.79K USD |
Valuation Analysis
Below Book Valuation: The market values Kelyniam Global Inc's assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Kelyniam Global Inc's assets grew by 8.3% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Kelyniam Global Inc (2006–2024)
The table below shows the annual total assets of Kelyniam Global Inc from 2006 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $1.77 Million | +8.33% |
| 2023-12-31 | $1.63 Million | -4.33% |
| 2022-12-31 | $1.71 Million | +19.25% |
| 2021-12-31 | $1.43 Million | +8.95% |
| 2020-12-31 | $1.31 Million | -13.77% |
| 2019-12-31 | $1.52 Million | +21.49% |
| 2018-12-31 | $1.25 Million | +7.34% |
| 2017-12-31 | $1.17 Million | -10.18% |
| 2016-12-31 | $1.30 Million | +7.44% |
| 2015-12-31 | $1.21 Million | -7.99% |
| 2014-12-31 | $1.32 Million | -1.69% |
| 2013-12-31 | $1.34 Million | +1875.28% |
| 2007-12-31 | $67.74K | -18.93% |
| 2006-12-31 | $83.56K | -- |